Results 161 to 170 of about 42,854 (222)

High prevalence of cerebral venous sinus thrombosis in seven Chinese patients with cystathionine β-synthase deficiency

, 2020
Yanbin Wen, Jun Chen, Li‐Jun Xiao, Jie Feng, Wenping Gu   +4 more
openalex   +1 more source

Research Progress of Annexin A1 and Its Derived Peptides in the Diagnosis and Treatment of Circulatory Diseases

Immunity, Inflammation and Disease, Volume 13, Issue 11, November 2025.
ABSTRACT Background Annexin A1 (ANXA1), a calcium‐dependent phospholipid‐binding protein, plays a critical role in regulating inflammation, apoptosis, immune responses, and vascular remodeling. It is increasingly recognized for its potential as a therapeutic target and diagnostic biomarker in various circulatory diseases, including sepsis, hypertension,
Qiuyu Dai, Jie Zheng, Meng Fu, Song Qin, Xiaoyun Fu   +4 more
wiley   +1 more source

Pediatric liver transplantation. Part II. Diagnostic imaging in postoperative management [PDF]

, 1985
Bron, KM, Cienfuegos, X, Dominguez, K, Gartner, JC, Ledesma-Medina, L, Starzl, TE, Young, LW   +6 more
core   +1 more source

The Evolving Trend of Liver Transplantation in Metabolic Diseases: From Origins to Current Perspectives

Journal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT Liver transplantation (LTx) has become, over the years, an increasingly used therapeutic option in patients with inherited metabolic diseases (IMD). Initially performed for Tyrosinemia Type I and ornithine transcarbamylase deficiency, it now accounts as the second indication for pediatric transplants worldwide. The use of LTx has been extended
Andrea Pietrobattista, Diego Martinelli, Marco Spada, Carlo Dionisi‐Vici   +3 more
wiley   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): The Multifaceted Biology, Diseases, and Pharmaceutical Interventions

MedComm, Volume 6, Issue 11, November 2025.
Summary of PCSK9 inhibitor mechanisms. PCSK9 inhibitors (PCSK9‐i) primarily lower LDL‐cholesterol (LDL‐C) by blocking PCSK9‐mediated degradation of hepatic LDL receptors (LDLR), enhancing LDL clearance. Beyond LDLR‐dependent effects, PCSK9‐i exert multiple benefits via LDLR‐independent pathways.
Jia Kuang, Lei Hao, Meibiao Zhang, Zhao Yang   +3 more
wiley   +1 more source

Cerebral Venous Thrombosis with Migraine-Like Headache and the Trigeminovascular System [PDF]

, 2016
Fábio A. Nascimento, Marília Grando Sória, Vanessa Rizelio, Pedro André Kowacs   +3 more
openalex   +1 more source

Aberrant Expression of A Disintegrin and Metalloproteinase With Thrombospondin Motifs 13 (ADAMTS13) in Pancreatic Cancer Leads to Dichotomic Functions

MedComm, Volume 6, Issue 11, November 2025.
Allmang et al. demonstrated that ADAMTS13 is overexpressed in PDAC, associated with prolonged survival and reduced vascular density. Knockout of ADAMTS13 in PDAC cells led to a decrease in migration and invasion. In a xenograft model, loss of ADAMTS13 altered angiogenesis, vascular maturation, and reduced the expression of key angiogenic factors ...
Stephanie Allmang, Hagen R. Witzel, Anne Hausen, Simone Marquard, Christoph Eckert, Nicole Marnet, Nina Hörner, Philipp Mayer, Stefan Heinrich, Hien Dang, Wilfried Roth, Matthias M. Gaida   +11 more
wiley   +1 more source

Perinatal Outcomes After the Use of Kampo Medicines Containing Ephedra During Pregnancy

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 11, November 2025.
ABSTRACT Purpose Japanese traditional (Kampo) medicines containing ephedra are used to relieve symptoms of the common cold during pregnancy. The risks associated with perinatal outcomes, however, remain unclear. Thus, we evaluated the risk of adverse perinatal outcomes associated with the use of Kampo medicines containing ephedra during pregnancy using
Aoi Noda, Ryutaro Arita, Taku Obara, Minoru Ohsawa, Satoko Suzuki, Ken Haneda, Ryo Obara, Kei Morishita, Genki Shinoda, Keiko Murakami, Masatsugu Orui, Mami Ishikuro, Akiko Kikuchi, Shin Takayama, Tadashi Ishii, Shinichi Kuriyama   +15 more
wiley   +1 more source

Letter by Stam Regarding Article, “Anticoagulants for Cerebral Venous Thrombosis: Harmful to Patients?” [PDF]

, 2014
J. Stam
openalex   +1 more source

Treatment‐Specific Risk Scales for Identifying High‐Risk Patients With Poor Prognosis in Acute Ischemic Stroke: A Cohort Study From the National Neurological Medical Center of China

CNS Neuroscience &Therapeutics, Volume 31, Issue 11, November 2025.
The PAIST prognostic tool, developed through thrombolysis‐based stratification and externally validated, effectively identifies AIS patients at high risk of acute‐phase adverse outcomes by integrating multidimensional variables, demonstrating superior predictive performance to support clinical management.
Yi Xu, Shenyi Kuang, Shilin Yang, Jianfeng Luo, Chun Yu, Xiaocui Kang, Xiang Han, Qiang Dong   +7 more
wiley   +1 more source